Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Noriko Otsuki
Observed names:
N. Otsuki,
Otsuki, Noriko
Institution:
Tokyo Women's Medical University
Observed institutions:
Tokyo Medical and Dental University,
Tokyo Women's Medical University,
National Institute of Health Sciences,
Institute of Medical Science, The University of Tokyo,
The University of Tokyo
ORCID:
0000-0003-0848-6458
Observed ORCID:
0000-0003-0848-6458
OpenAlex ID:
A5059162346
Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer
2005
·
Yuichiro Ohigashi
, Masayuki Sho
, et al.
·
Clinical Cancer Research
·
862
PDF
Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects
2009
·
Noriko Otsuki
, Nam H. Dang
, et al.
·
Journal of Ethnopharmacology
·
484
Differential binding properties of B7-H1 and B7-DC to programmed death-1
2003
·
Pornpan Youngnak
, Yuko Kozono
, et al.
·
Biochemical and Biophysical Research Communications
·
233
Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses
2003
·
Fumihiko Tsushima
, Hideyuki Iwai
, et al.
·
European Journal of Immunology
·
129
PDF
Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma
2005
·
Fumihiko Tsushima
, Kae Tanaka
, et al.
·
Oral Oncology
·
112
Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells
2006
·
Noriko Otsuki
, Yousuke Kamimura
, et al.
·
Biochemical and Biophysical Research Communications
·
96
The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role
2004
·
Pornpan Youngnak-Piboonratanakit
, Fumihiko Tsushima
, et al.
·
Immunology Letters
·
74
Intrahepatic expression of the co‐stimulatory molecules programmed death‐1, and its ligands in autoimmune liver disease
2007
·
Tsunekazu Oikawa
, Hiroki Takahashi
, et al.
·
Pathology International
·
61
Stat6 activation and Th2 cell proliferation driven by CD28 signals
2000
·
Shinji Oki
, Noriko Otsuki
, et al.
·
European Journal of Immunology
·
29
PDF
A new biomarker candidate for spinal muscular atrophy: Identification of a peripheral blood cell population capable of monitoring the level of survival motor neuron protein
2018
·
Noriko Otsuki
, Reiko Arakawa
, et al.
·
PLoS ONE
·
27
PDF
Allergen‐specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co‐inhibitory molecule, in allergic rhinitis
2008
·
M. Okano
, N. Otsuki
, et al.
·
Clinical & Experimental Allergy
·
27
Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses
2012
·
Masaaki Hashiguchi
, Yuka Inamochi
, et al.
·
Open Journal of Immunology
·
12
PDF
Expression and Regulation of Human CD275 on Endothelial Cells in Healthy and Inflamed Mucosal Tissues
2006
·
P. Youngnak‐Piboonratanakit
, F. Tsushima
, et al.
·
Scandinavian Journal of Immunology
·
12
Imaging Flow Cytometry Analysis to Identify Differences of Survival Motor Neuron Protein Expression in Patients With Spinal Muscular Atrophy
2016
·
Reiko Arakawa
, Masayuki Arakawa
, et al.
·
Pediatric Neurology
·
8
Replication stress increases mitochondrial metabolism and mitophagy in FANCD2 deficient fetal liver hematopoietic stem cells
2023
·
Makiko Mochizuki-Kashio
, Noriko Otsuki
, et al.
·
Frontiers in Oncology
·
7
PDF
Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment
2025
·
Tamaki Kato
, Noriko Otsuki
, et al.
·
Brain and Development
·
5
PDF
Analysis of SMN protein in umbilical cord blood and postnatal peripheral blood of neonates with SMA: a rationale for prompt treatment initiation to prevent SMA development
2025
·
Noriko Otsuki
, Tamaki Kato
, et al.
·
Orphanet Journal of Rare Diseases
·
5
Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-I
2015
·
Noriko Otsuki
, Satoshi Iwata
, et al.
·
Modern Rheumatology
·
3
Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report
2026
·
Yukimune Okubo
, Noriko Togashi
, et al.
·
Brain and Development
·
1
Reply to “Comment on ‘Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment’”
2025
·
Tamaki Kato
, Noriko Otsuki
, et al.
·
Brain and Development
Method of Evaluating Survival Motor Neuron Protein As An Outcome Measure of SMA-modifying Therapy
2017
·
Reiko Arakawa
, Arakawa Masayuki
, et al.
·
Brain and Development
Show more works
View as search
Works count:
26
Citation count:
2,187
H-index:
12
I10-index:
13
Year
Topic
Type